ENTITY

Kissei Pharmaceutical (4547 JP)

21

Analysis

Health Care • Japan

KISSEI PHARMACEUTICAL CO., LTD. manufactures and sells a variety of prescription drugs. The Company's main products are for cholesterol, high blood pressure, digestion, allergy, circulatory and respiratory diseases, and Parkinson's disease.

more

Refresh

Exchange Announcement • 23 Dec 2024 07:45

Regarding The Approval Of The Additional Indication For Endometriosis In Europe For The Gnrh Antagonist Yselty (Generic Name Linzagolix) .

Exchange Announcement • 06 Nov 2024 15:00

Financial Briefing For The Second Quarter (Interim) Of The Fiscal Year Ended March 31, 2025 (Fiscal 2024)

Exchange Announcement • 06 Nov 2024 09:00

Notice Concerning The Results Of The Acquisition Of Treasury Shares, Through Off-Auction Treasury Share Repurchase Trading System (Tostnet-3)

Exchange Announcement • 05 Nov 2024 15:30

Supplementary Explanatory Materials On Financial Results For The Six Months Ended September 30, 2024

Exchange Announcement • 05 Nov 2024 15:30

Notice On The Acquisition Of Treasury Shares, The Acquisition Of Treasury Shares Through Off-Auction Own Share Repurchase Trading System (Tostnet-3)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x